Literature DB >> 1743353

Complications of 5--fluorouracil after trabeculectomy.

W A Franks1, R A Hitchings.   

Abstract

Trabeculectomy has a very high success rate, however, certain eyes are known to be at high risk of failure due to scarring of the conjunctival bleb. Such eyes include those with a previous failed filter, eyes with glaucoma secondary to uveitis and neovascularisation and the eyes of children and young adults. Trabeculectomy is generally accepted to have less successful results in patients of African race although good results are reported from some centres. The effectiveness of treatment with 5-fluorouracil in improving the results of trabeculectomy has been established in a number of pilot studies and clinical trials. Early studies used 100 mg of 5-fluorouracil in divided doses. Serious complications were recorded and lower dose regimes have been advised to improve the safety of the technique. Similar success in improving the chance of success to trabeculectomy has been found with doses of 40 mg with a lower incidence of side effects. We report complications associated with the use of 5-fluorouracil in a total dose of 50 mg in a group of 49 eyes undergoing trabeculectomy and postoperative 5-fluorouracil and describe the previously unreported increased incidence of thin cystic blebs in these eyes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1743353     DOI: 10.1038/eye.1991.63

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  Trypan blue staining of antiproliferative agents for trabeculectomy surgery and bleb needling.

Authors:  W Franks
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

2.  Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.

Authors:  Jung Hwa Na; Kyung Rim Sung; Jin A Shin; Jung Il Moon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-06-07       Impact factor: 3.117

3.  Long term growth arrest of human Tenon's fibroblasts following single applications of beta radiation.

Authors:  P H Constable; J G Crowston; N L Occleston; M F Cordeiro; P T Khaw
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

4.  Viscocanalostomy versus trabeculotomy ab externo in primary congenital glaucoma: 1-year follow-up of a prospective controlled pilot study.

Authors:  B N Noureddin; C P El-Haibi; A Cheikha; Z F Bashshur
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

5.  The effect of intraoperative injection of hyaluronan under a one-piece glaucoma filtration implant in the rabbit eye.

Authors:  M Kivalo; T Hollmén; A Sukura; T Mononen
Journal:  Acta Vet Scand       Date:  1997       Impact factor: 1.695

Review 6.  Beta radiation for glaucoma surgery.

Authors:  James F Kirwan; Christina Rennie; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

7.  Pharmacokinetics of pirfenidone after topical administration in rabbit eye.

Authors:  Guoying Sun; Xianchai Lin; Hua Zhong; Yangfan Yang; Xuan Qiu; Chengtian Ye; Kaili Wu; Minbin Yu
Journal:  Mol Vis       Date:  2011-08-13       Impact factor: 2.367

8.  The use of amniotic membrane in trabeculectomy for the treatment of primary open-angle glaucoma: a prospective study.

Authors:  Panagiotis Stavrakas; Gerasimos Georgopoulos; Maria Milia; Dimitris Papaconstantinou; Maria Bafa; Efthymios Stavrakas; Mihalis Moschos
Journal:  Clin Ophthalmol       Date:  2012-02-02

9.  Trabeculectomy with Healaflow versus Trabeculectomy for the Treatment of Glaucoma: A Case-Control Study.

Authors:  Dimitris Papaconstantinou; Andreas Diagourtas; Petros Petrou; Alexandros Rouvas; Athanasios Vergados; Chryssanthi Koutsandrea; Ilias Georgalas
Journal:  J Ophthalmol       Date:  2015-06-11       Impact factor: 1.909

10.  AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.

Authors:  Wen-Sheng Cheng; Ching-Long Chen; Jiann-Torng Chen; Le-Tien Lin; Shu-I Pao; Yi-Hao Chen; Da-Wen Lu
Journal:  Molecules       Date:  2020-09-26       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.